Protein biomarkers and major cardiovascular events in older people with advanced CKD: the European quality (EQUAL) study

Hayward, S.J.L.; Chesnaye, N.C.; Hole, B.; Aylward, R.; Meuleman, Y.; Torino, C.; ... ; EQUAL Investigators (2023)

Article / Letter to editor

Rationale & Objective: Cardiovascular disease is the leading cause of morbidity and mortality in chronic kidney disease (CKD). We investigated 184 inflammatory and cardiovascular proteins to determine their potential as biomarkers for major cardiovascular events (MACEs).Study Design: The European Quality (EQUAL) is an observational cohort study that enrolled people aged >= 65 years with an estimated glomerular filtration rate <= 20 mL/min/1.73 m(2).Setting & Participants: Recruited participants were split into the discovery (n = 611) and replication cohorts (n = 292).Exposure: Levels of 184 blood proteins were measured at the baseline visit, and each protein was analyzed individually.Outcome: MACE.Analytical Approach: Cox proportional hazard models adjusted for age, sex, estimated glomerular filtration rate, previous MACE, and country were used to determine the risk of MACE. Proteins with false discovery rate adjusted P values of <0.05 in the discovery cohort were tested in the replication cohort. Sensitivity analyses were performed by adjusting for traditional risk factors, CKD-specific risk factors, and level of proteinuria and segregating atherosclerotic and nonatherosclerotic MACE.Results: During a median follow-up of 2.9 years, 349 people (39%) experienced a MACE. Forty-eight proteins were associated with MACE in the discovery cohort; 9 of these were reproduced in the replication cohort. Three of these proteins maintained a strong association with MACE after adjustment for traditional and CKD-specific risk factors and proteinuria. Tenascin (TNC), fibroblast growth factor-23 (FGF-23), and V-set and immunoglobulin domain-containing protein 2 (VSIG2) were associated with both atherosclerotic and nonatherosclerotic MACE. All replicated proteins except carbonic anhydrase 1 and carbonic anhydrase 3 were associated with nonatherosclerotic MACE.Limitations: Single protein concentration measurements and limited follow-up time.Conclusions: Our findings corroborate previously reported relationships between FGF-23, vascular cell adhesion protein-1, TNC, and placental growth factor with cardiovascular outcomes in CKD. We identify 5 proteins not previously linked with MACE in CKD that may be targets for future therapies.

• All authors: Hayward, S.J.L.; Chesnaye, N.C.; Hole, B.; Aylward, R.; Meuleman, Y.; Torino, C.; Porto, G.; Szymczak, M.; Drechsler, C.; Dekker, F.W.; Evans, M.; Jager, K.J.; Wanner, C.; Caskey, F.J.; EQUAL Investigators
• Date: 2023-12-07
• Journal: KIDNEY MEDICINE
• Volume: 6
• Issue: 1
• DOI: doi:10.1016/j.xkme.2023.100745